智通财经APP讯,石四药集团(02005)发布截至2024年12月31日止年度业绩,集团收益57.73亿港元,同比减少10.67%;股东应占溢利10.61亿港元,同比减少19.53%;每股基本盈利0.3582港元;拟派末期息每股0.095港元。一年来,集团持续提升产品的市场可及性。2024年,集团克服不利因素影响,扎实做好新产品获批与各地上市准入工作的有效衔接,不失时机参与国家集采接续和省际及地方...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.